A Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR).
Clinical trial NCT06997159 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06997159
- Sponsor
- Drugs for Neglected Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-15
- Primary completion
- 2028-04-05
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.